Viewing Study NCT05544032


Ignite Creation Date: 2025-12-24 @ 9:42 PM
Ignite Modification Date: 2025-12-25 @ 7:23 PM
Study NCT ID: NCT05544032
Status: AVAILABLE
Last Update Posted: 2025-10-08
First Post: 2022-09-14
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Expanded Access of Axatilimab to Treat a Single Patient With Chronic Graft Versus Host Disease (GVHD)
Sponsor: Incyte Corporation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module